Related references
Note: Only part of the references are listed.Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations
Viviane C. Longuini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease
Andrea Osswald et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Changes in Plasma ACTH Levels and Corticotroph Tumor Size in Patients With Cushing's Disease During Long-term Treatment With the Glucocorticoid Receptor Antagonist Mifepristone
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Treatment of Cushing's disease: a mechanistic update
Daniel Cuevas-Ramos et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo
Shingo Murasawa et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Results of Immunohistochemical Staining of Cell-Cycle Regulators: The Prediction of Recurrence of Functioning Pituitary Adenoma
Eun Hee Lee et al.
WORLD NEUROSURGERY (2014)
Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior
Alberto Righi et al.
HUMAN PATHOLOGY (2013)
MicroRNA-200c Inhibits Apoptosis in Pituitary Adenoma Cells by Targeting the PTEN/Akt Signaling Pathway
Chuangxin Liao et al.
ONCOLOGY RESEARCH (2013)
Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
Aurelie Cornelius et al.
BRAIN PATHOLOGY (2012)
The burden of Cushing's disease: clinical and health-related quality of life aspects
R. A. Feelders et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4
Koji Ueno et al.
MOLECULAR CANCER THERAPEUTICS (2012)
O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
Fateme Salehi et al.
NEUROSURGERY (2012)
Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10
Antonio J. Martinez-Fuentes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Analysis of differential gene expression using fiber-optic bead array and pathway analyses in pituitary adenomas
Zhiquan Jiang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices
Iman H. Hewedi et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2011)
Analysis of IMP3 Expression in Normal and Neoplastic Human Pituitary Tissues
Alberto Righi et al.
ENDOCRINE PATHOLOGY (2010)
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli
Federico Tagliati et al.
ENDOCRINOLOGY (2010)
Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas
Yuji Tani et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas
Elaine Lu Wang et al.
HISTOPATHOLOGY (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and-493 in pituitary carcinomas
Gail Stilling et al.
ENDOCRINE (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Expression of p18INK4C is Down-regulated in Human Pituitary Adenomas
Md. Golam Hossain et al.
ENDOCRINE PATHOLOGY (2009)
Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma
K. Revill et al.
ENDOCRINE-RELATED CANCER (2009)
MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
Fernando Colbari Amaral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
Zhi Rong Qian et al.
MODERN PATHOLOGY (2009)
Wnt pathway inhibitors are strongly down-regulated in pituitary tumors
Marianne S. Elston et al.
ENDOCRINOLOGY (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Expression of neurotensin and its receptors in pituitary adenomas
R. R. Giorgi et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas
YunFeng Yuan et al.
MODERN PATHOLOGY (2008)
P75(NTR) and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas
Martha Assimakopoulou et al.
NEUROENDOCRINOLOGY (2008)
Differential gene expression in ACTH-secreting and non-functioning pituitary tumors
Torn Tateno et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas
Zhi Rong Qian et al.
MODERN PATHOLOGY (2007)
Differential expression of neurogenins and NeuroD1 in human pituitary tumours
A. Fratticci et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas
Arianna Bottoni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study
Mariagiovanna Filippella et al.
CLINICAL ENDOCRINOLOGY (2006)
PTTG overexpression is correlated with angiogenesis in human pituitary adenomas
Takeo Minematsu et al.
ENDOCRINE PATHOLOGY (2006)
Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas
R Buslei et al.
ACTA NEUROPATHOLOGICA (2006)
Evaluation and treatment of Cushing's syndrome
LK Nieman et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Enhanced protein kinase B/Akt signalling in pituitary tumours
M Musat et al.
ENDOCRINE-RELATED CANCER (2005)
Galectin-3 expression in functioning and silent ACTH-producing adenomas
L Jin et al.
ENDOCRINE PATHOLOGY (2005)
KiSS-1 and GPR54 as new players in gonadotropin regulation and puberty
UB Kaiser et al.
ENDOCRINE (2005)
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: Relation to tumor type, size, proliferation, and invasiveness
ZR Qian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The prevalence of pituitary adenomas - A systematic review
S Ezzat et al.
CANCER (2004)
Differential expression of menin in sporadic pituitary adenomas
M Theodoropoulou et al.
ENDOCRINE-RELATED CANCER (2004)
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1
E Ferretti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)
Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas:: a prereceptor determinant of pituitary cell proliferation
E Rabbitt et al.
ONCOGENE (2003)
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour
CJ McCabe et al.
CLINICAL ENDOCRINOLOGY (2003)
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas
DG Morris et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours
LA Tannahill et al.
CLINICAL ENDOCRINOLOGY (2002)
Immunohistochemical analysis of RCAS1 in human pituitary adenomas
K Umeoka et al.
MODERN PATHOLOGY (2001)
The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54
M Kotani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of neuro D1 in human normal pituitaries and pituitary adenomas
K Oyama et al.
MODERN PATHOLOGY (2001)
Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas
K Komatsubara et al.
ENDOCRINE PATHOLOGY (2001)
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor
T Ohtaki et al.
NATURE (2001)
Securin is required for chromosomal stability in human cells
PV Jallepalli et al.
CELL (2001)
CDKN2A/p16 inactivation is related to pituitary adenoma type and size
N Seemann et al.
JOURNAL OF PATHOLOGY (2001)
Identification of c-myc as a down-stream target for pituitary tumor-transforming gene
L Pei
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
